Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Dec 24, 2015 in Benign prostatic hyperplasia | 4 comments

In a nutshell

This study investigated the effects of statin treatment on benign prostatic hyperplasia (BPH). Statins were found to significantly reduce prostate size and improve urinary symptoms. 

Some background

Statins, such as simvastatin (Zocor) and atorvastatin (Lipitor), are common drugs used to reduce cholesterol levels. Updated guidelines by the American Heart Association recommend that statins be taken by adults with an increased risk for cardiovascular events (heart or blood vessel disease, such as heart attacks or strokes). Obesity, high cholesterol levels, high blood pressure, high blood sugar levels, high triglyceride levels, smoking and diabetes, are all common risk factors for such events.

Although the exact cause for BPH remains unknown, recent studies have suggested a link between risk factors for cardiovascular events and prostate disease. Therefore, researchers theorized that statin treatment may be of benefit in the treatment of BPH.

Methods & findings

124 patients participated in this study. Men were randomly assigned to receive simvastatin (43 men), atorvastatin (40 men), or a placebo (control group, 41 men), for 12 months. Cholesterol and sugar levels, prostate-specific antigen (PSA, a protein used to estimate prostate growth), prostate size, BPH symptoms, and indicators of inflammation (such as IL-6 and CRP, measured by blood tests), were tested before and after treatment.

Total cholesterol, triglyceride, LDL-cholesterol and inflammation marker (CRP and IL-6) levels were all decreased with statin treatment compared to placebo. Prostate size and patient reported BPH symptoms were also reduced with statin treatment. Patients who received simvastatin showed greater prostate size reduction than those receiving atorvastatin. The decrease in prostate size with statins was more significant in obese patients than in the normal weight patients.

The bottom line

Researchers concluded that statins significantly reduce prostate size, improve urinary symptoms, and slow the progression of BPH.

The fine print

The exact mechanism by which statins affect BPH has not been clarified, and further research is needed. 

What’s next?

Consult with your physician on the potential risks and benefits of statin treatment.

Published By :

World Journal of Urology

Date :

Dec 01, 2015

Original Title :

The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.

click here to get personalized updates